Physician profile
Christopher A Walker
NPI 1013932011
$17,611.45
in general payments reported to CMS, 2019-2025
36 companies · $747 in 2025
The $747 reported for 2025 was more than what 88% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $867 · 2020: $1,156 · 2021: $969 · 2022: $1,413 · 2023: $12K · 2024: $384 · 2025: $747.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $10K · Food and Beverage: $1,920 · Travel and Lodging: $1,286.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,000.00 |
| Food and Beverage | $1,919.97 |
| Travel and Lodging | $1,285.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,885.66 | 2023-2025 | Da Vinci Sp, Da Vinci Surgical System |
| Medtronic, INC. | $2,800.48 | 2021-2023 | Interstim |
| Abbvie INC. | $1,167.41 | 2019-2025 | Lo Loestrin Fe, Orilissa, Botox |
| Coloplast Corp | $934.42 | 2019-2023 | Altis |
| Allergan, INC. | $471.56 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $357.37 | 2021-2023 | |
| Myovant Sciences INC. | $241.12 | 2021-2022 | |
| Pfizer INC. | $194.86 | 2019-2024 | |
| Medline Industries LP | $171.69 | 2019 | |
| Therapeuticsmd, INC. | $143.90 | 2019-2022 | |
| Zyla Life Sciences, INC. | $139.67 | 2020 | |
| Duchesnay USA Incorporated | $133.86 | 2019 | |
| Roche Diagnostics Corporation | $106.82 | 2020 | |
| Axonics, INC. | $85.57 | 2020-2024 | Axonics |
| Sumitomo Pharma America, INC. | $71.51 | 2023 | Myfembree, Gemtesa |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $66.12 | 2022 | |
| Heron Therapeutics, INC. | $65.50 | 2022-2023 | Aponvie |
| Mentor Worldwide LLC | $65.03 | 2019 | |
| Currax Pharmaceuticals LLC | $60.16 | 2022 | |
| Antares Pharma, INC. | $49.50 | 2022 | |
| Teleflex LLC | $49.12 | 2024 | Solesta |
| Avion Pharmaceuticals | $39.86 | 2021-2022 | |
| Organon LLC | $39.66 | 2023 | Nexplanon |
| Mylan Pharmaceuticals INC. | $38.41 | 2020-2022 | |
| Becton, Dickinson and Company | $32.92 | 2023 | Bd Onclarity |
| Urovant Sciences INC | $28.90 | 2022 | |
| Osiris Therapeutics INC. | $23.24 | 2019 | |
| 180 Medical, INC. | $22.55 | 2024 | |
| Baxter Healthcare | $19.28 | 2019 | |
| Evofem Biosciences, INC. | $18.29 | 2020 | |
| Exeltis, USA INC. | $17.64 | 2019 | |
| Hologic Sales and Service, LLC | $17.02 | 2023 | Aptima, Thinprep 2000 Processor |
| Ascend Therapeutics US, LLC | $16.60 | 2019 | |
| Scynexis, INC. | $16.11 | 2022 | |
| Gynesonics, INC. | $15.52 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Assertio Therapeutics, INC. | $4.12 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.